2016
DOI: 10.1177/0891988716678684
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease

Abstract: Treatment of apathy in AD is a complicated and an underexplored field. Standardized and systematic efforts primarily focused on the study of apathy in AD may establish a benefit from individualized treatment for specific disease groups that would stem from a combination of both pharmacological and nonpharmacological interventions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
32
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 52 publications
(35 citation statements)
references
References 163 publications
(225 reference statements)
1
32
0
Order By: Relevance
“…Two systematic reviews of systematic reviews (Abraha et al, 2017;Vilela, Pacheco, Latorraca, Pachito, & Riera, 2017) reveal that non-pharmacological interventions have positive effects on reducing BPSD, improving cognitive function, activities of daily living, and social interaction ability of patients with dementia. For apathy, there are several systematic reviews and meta-analyses (Brodaty & Burns, 2012;Fukushima et al, 2016;Goris, Ansel, & Schutte, 2016;Lane-Brown & Tate, 2009;Theleritis, Siarkos, Katirtzoglou, & Politis, 2016;Theleritis, Siarkos, Politis, Katirtzoglou, & Politis, 2018;Tsoi et al, 2018;Verkaik, Weert, & Francke, 2005;Zafra-Tanaka, Pacheco-Barrios, Tellez, & Taype-Rondan, 2019) of non-pharmacological interventions in patients with dementia. Nevertheless, these reviews involve diversified non-pharmacological interventions and lack evaluation of methodological quality and classification of evidence quality.…”
Section: Introductionmentioning
confidence: 99%
“…Two systematic reviews of systematic reviews (Abraha et al, 2017;Vilela, Pacheco, Latorraca, Pachito, & Riera, 2017) reveal that non-pharmacological interventions have positive effects on reducing BPSD, improving cognitive function, activities of daily living, and social interaction ability of patients with dementia. For apathy, there are several systematic reviews and meta-analyses (Brodaty & Burns, 2012;Fukushima et al, 2016;Goris, Ansel, & Schutte, 2016;Lane-Brown & Tate, 2009;Theleritis, Siarkos, Katirtzoglou, & Politis, 2016;Theleritis, Siarkos, Politis, Katirtzoglou, & Politis, 2018;Tsoi et al, 2018;Verkaik, Weert, & Francke, 2005;Zafra-Tanaka, Pacheco-Barrios, Tellez, & Taype-Rondan, 2019) of non-pharmacological interventions in patients with dementia. Nevertheless, these reviews involve diversified non-pharmacological interventions and lack evaluation of methodological quality and classification of evidence quality.…”
Section: Introductionmentioning
confidence: 99%
“…One recent article from January 2017 reviewed recent pharmacological and non-pharmacological approaches for the management of apathy in AD (Theleritis et al, 2017) and reported the potential interest of cholinesterase inhibitors (ChEIs), methylphenidate and gingko biloba in reducing levels of apathy, whereas Sepehry et al's review did not reveal any significant treatment effect likely to reduce apathy in AD (Sepehry et al, 2017). In Theleritis, among 6 studies using galantamine (4 RCT and 2 open-label studies), five studies did show an improvement of apathy levels after treatment.…”
Section: Reviews and Meta-analysesmentioning
confidence: 99%
“…Even when apathy is recognized, clinicians and families face the additional challenge of identifying adequate treatments. Both pharmacological and nonpharmacological interventions currently lack the prevision needed to target specific apathy subtypes and their underlying mechanisms; nor do they take into account common comorbidities, such as depression, that frequently complicate the management of BPSDs …”
Section: Further Considerations For Intervention Researchmentioning
confidence: 99%